Glaxosmithkline Pharmaceuticals Ltd.

Name: Glaxosmithkline Pharmaceuticals Ltd. Share Price Today, Stock Analysis
Brand: Glaxosmithkline Pharmaceuticals Ltd.

Stock Card

NSE: GLAXO | BSE: 500660

₹2,315.00

₹48.80 (2.15%)

As on 19-Jun-2026 10:09IST

Market cap

₹38,402 Cr

Revenue (TTM)

₹3,822 Cr

P/E Ratio

37.1

P/B Ratio

16.8

Div. Yield

2.5 %

Value Research Rating

Quality Score

10/10

Growth Score

6/10

Valuation Score

5/10

Momentum Score

1/10

Know more

Explore 5 star rated stocks

Glaxosmithkline Pharma Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 2,237.60 High: 2,318.20

52 Week Range

Low: 2,088.10 High: 3,500.00

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

₹1,036 Cr
ROE

48.8 %
ROCE

66.8 %
Industry P/E

35.06
EV/EBITDA

25.4
Debt to Equity

0
Book Value

₹134.8
EPS

₹61.2
Face value

10
Shares outstanding

169,406,034

10 Years Aggregate

CFO

₹6,255.25 Cr

EBITDA

₹7,742.38 Cr

Net Profit

₹5,055.34 Cr

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Glaxosmithkline Pharma	-6.4	-3.1	-5.0	-29.6	17.7	8.8	2.8
BSE Healthcare	9.7	0.7	11.6	10.4	23.9	14.0	12.4

As on 19-Jun-2026

Company	2025	2024	2023	2022	2021	2020	2019
Glaxosmithkline Pharma	10.8	15.4	43.9	-24.9	9.0	-0.5	7.5
BSE Mid Cap	1.1	25.8	45.5	1.4	39.2	19.9	-3.0
BSE Healthcare	-3.3	43.1	37.0	-12.1	20.9	61.4	-3.5

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price (₹)	Market Cap (₹ Cr)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Glaxosmithkline Pharma	2,315.0	38,401.8	3,821.7	1,036.0	32.5	48.8	37.1	16.8
Abbott India	26,135.0	55,513.8	6,929.1	1,552.0	26.2	35.3	35.8	11.6
Alkem Laboratories	5,352.5	64,302.1	14,712.3	2,353.1	17.8	17.7	27.9	4.7
Aurobindo Pharma	1,461.8	83,029.9	33,653.1	3,501.5	14.9	9.7	23.7	2.2
Biocon	416.8	67,048.9	16,927.0	368.8	8.8	-0.6	173.9	2.0
Ipca Laboratories	1,584.9	39,177.0	9,646.3	1,191.4	16.2	15.5	34.3	4.9
Lupin	2,324.0	1,06,420.9	27,958.0	5,355.5	26.6	27.4	20	4.7
Mankind Pharma	2,411.6	99,323.5	14,277.6	1,926.4	19.1	12.8	51.9	6.1
Sun Pharmaceutical	1,831.3	4,37,638.7	58,462.0	11,564.5	23.9	15.4	38.1	5.2
Zydus Lifesciences	1,073.0	1,08,099.7	27,148.4	5,026.4	21.9	20.7	21.4	4.0

Shareholding Pattern

View Details

News & Analysis

All News

Decoding capital expenditure

1 min read•By Research Desk

The quest for value

2 min read•By Mohammed Ekramul Haque

Pedigree in Lifestyle

3 min read•By Research Desk

Living The Larger Life

4 min read•By Research Desk

In The Pink Of Health

2 min read•By Research Desk

Nasdaq Tremors Rock Dalal Street

2 min read•By Markets Desk

About Glaxosmithkline Pharma

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis,... hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease; Boostrix for immunization against diphtheria, tetanus and pertussis; Fluarix Tetra for the prevention of influenza disease; Varilrix for active immunization against varicella; and Shingrix for prevention of herpes zoster and post-herpetic neuralgia. It also provides specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; and Trelegy Ellipta for treating chronic obstructive pulmonary disease. In addition, the company offers general medicines, including AUGMENTIN and CEFTUM, an oral antibiotic to treat bacterial infections; CobadexCZS to treat mineral and vitamins deficiency states; Flutivate, a skin cream for adults, children, and infants; Tenovate to treat inflammatory and pruritic manifestations of steroid responsive dermatosis; CALPOL to treat mild to moderate pain; ELTROXIN for hypothyroidism; CCM to treat calcium and vitamin D deficiency; NEOSPORIN for treatment of specific bacterial skin infections; BETNOVATE for skin conditions; T-BACT for bacterial skin infections; and PHYSIOGEL for dry skin associated with redness and itch. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. The company was incorporated in 1924 and is based in Mumbai, India. GlaxoSmithKline Pharmaceuticals Limited operates as a subsidiary of GSK plc. Read more